- · 《临床药物治疗杂志》编[10/30]
- · 《临床药物治疗杂志》杂[10/30]
- · 《临床药物治疗杂志》杂[10/30]
- · 《临床药物治疗杂志》期[10/30]
- · 《临床药物治疗杂志》数[10/30]
- · 《临床药物治疗杂志》投[10/30]
- · 临床药物治疗杂志版面费[10/30]
年系统性硬化症和大流行世界硬皮病基金会对患(5)
作者:网站采编关键词:
摘要:作者贡献:崔洁涵、刘爱京负责文章构思与设计、论文撰写与修改;杨林、汪晓平、何晶晶负责文献资料收集整理;彭晓欣、冯星负责文献质量控制;马隽
作者贡献:崔洁涵、刘爱京负责文章构思与设计、论文撰写与修改;杨林、汪晓平、何晶晶负责文献资料收集整理;彭晓欣、冯星负责文献质量控制;马隽负责文章审校与修改;刘爱京负责文章可行性分析,并对文章整体负责,监督管理。
本文无利益冲突。
[1]HUANG C L,WANG Y M,LI X W,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].Lancet,2020,395():497-506.DOI:10.1016/S0140-6736(20)-5.
[2]Coronaviridae Study Group of the International Committee on Taxonomy of Viruses.The species severe acute respiratory syndromerelated coronavirus:classifying 2019-nCoV and naming it SARSCoV-2[J].Nat Microbiol,2020,5(4):536-544.DOI:10.1038/s-020-0695-z.
[3]DENTON C P,KHANNA D.Systemic sclerosis[J].Lancet,2017,390():1685-1699.DOI:10.1016/S0140-6736(17)-9.
[4]MATUCCI-CERINIC M,BRUNI C,ALLANORE Y,et al.Systemic sclerosis and the COVID-19 pandemic:World Scleroderma Foundation preliminary advice for patient management[J].Ann Rheum Dis,2020,79(6):724-726.DOI:10.1136/annrheum dis-2020-.
[5]KOWAL-BIELECKA O,FRANSEN J,AVOUAC J,et al.Update of EULAR recommendations for the treatment of systemic sclerosis[J].Ann Rheum Dis,2017,76(8):1327-1339.DOI:10.1136/annrheumdis-2016-.
[6]MEHTA P,MCAULEY D F,BROWN M,et al.COVID-19:consider cytokine storm syndromes and immunosuppression[J].Lancet,2020,395():1033-1034.DOI:10.1016/S0140-6736(20)-0.
[7]D&APOS,ANTIGA L.Coronaviruses and immunosuppressed patients:the facts during the third epidemic[J].Liver Transpl,2020,26(6):832-834.DOI:10.1002/lt..
[8]国家卫生健康委疾控局.《公民防疫行为准则》(科普版)[EB/OL](2020-10-14)[2021-01-14].http:///jkj/s7934td//.
[9]MIHAI C,DOBROTA R,SCHR?DER M,et al.COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD[J].Ann Rheum Dis,2020,79(5):668-669.DOI:10.1136/annrheumdis-2020-.
[10]LI G D,DE CLERCQ E.Therapeutic options for the 2019 novel coronavirus(2019-nCoV)[J]. Nat Rev Drug Discov,2020,19(3):149-150.DOI:10.1038/d-020-00016-0.
[11]ZUMLA A,CHAN J F,AZHAR E I,et al.Coronaviruses-drug discovery and therapeutic options[J].Nat Rev Drug Discov,2016,15(5):327-347.
[12]MORSE J S,LALONDE T,XU S Q,et al.Learning from the past:possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV[J].ChemBioChem,2020,21(5):730-738.DOI:10.1002/cbic..
[13]DE CLERCQ E.New nucleoside analogues for the treatment of hemorrhagic fever virus infections[J].Chem Asian J,2019,14(22):39.
[14]中华人民共和国国家卫生健康委员会办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第八版)[J].中国医药,2020,10:1494-1499.http:///periodical/zhongguoyy002.
[15]DE WIT E,FELDMANN F,CRONIN J,et al.Prophylactic and therapeutic remdesivir(GS-5734) treatment in the rhesus macaque model of MERS-CoV infection[J].Proc Natl Acad Sci USA,2020,117(12):6771-6776.DOI:10.1073/pnas..
[16]TEJERO H,MONTERO F,NU?O J C.Theories of lethal mutagenesis:from error catastrophe to lethal defection[J].Curr Top Microbiol Immunol,2016,392:161-179.DOI:10.1007/82_2015_463.
[17]SHEAHAN T P,SIMS A C,GRAHAM R L,et al.Broadspectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J].Sci Transl Med,2017,9(396):eaal3653.DOI:10.1126/.
[18]HOLSHUE M L,DEBOLT C,LINDQUIST S,et al.First case of 2019 novel coronavirus in the United States[J].N Engl J Med,2020,382(10):929-936.DOI:10.1056/NEJMoa.
[19]BEIGEL J H,TOMASHEK K M,DODD L E,et al.Remdesivir for the treatment of COVID-19-final report[J].N Engl J Med,2020,383(19):1813-1826.DOI:10.1056/NEJMoa.
[20]WANG Y M,ZHANG D Y,DU G H,et al.Remdesivir in adults with severe COVID-19:a randomised,double-blind,placebocontrolled,multicentre trial[J].Lancet,2020,395():1569-1578.DOI:10.1016/S0140-6736(20)-9.
[21]HUNG I F,LUNG K C,TSO E Y,et al.Triple combination of interferon beta-1b,lopinavir-ritonavir,and ribavirin in the treatment of patients admitted to hospital with COVID-19:an openlabel,randomised,phase 2 trial[J].Lancet,2020,395():1695-1704.DOI:10.1016/S0140-6736(20)-4.
[22]CAO B,WANG Y M,WEN D N,et al.A trial of lopinavirritonavir in adults hospitalized with severe covid-19[J].N Engl J Med,2020,382(19):1787-1799.DOI:10.1056/NEJMoa.
文章来源:《临床药物治疗杂志》 网址: http://www.lcywzlzz.cn/qikandaodu/2021/0622/1182.html